About Schrödinger
Schrödinger is a publicly listed company based in New York (United States) founded in 1990 by William A Goddard, and was acquired by Baron Funds in May 2020. Schrödinger is recognized for developing physics-based software platforms for molecular discovery. It operates on a SaaS (Software-as-a-Service) and Professional Services model in Industrial Goods & Manufacturing, Healthcare, and Technology sectors. Schrödinger has raised $162 million across 10 funding rounds from investors including WuXi AppTec, Gates Foundation and HHS. The company has 891 employees. Its chief executive, as recorded, is Ramy Farid. Its website schrodinger.com draws about 197 thousand monthly visits. Its Indian entity Schrodinger India Private Limited reported revenue of ₹138 Cr. Schrödinger offers products and services including Maestro, LiveDesign, MS Maestro, and FEP+. Its focus areas include Software, Scientific Software, Biotechnology and Drug Discovery. Its competitors include Nimbus Therapeutics, EvolutionaryScale and Evozyne; 3 of its 3 listed competitors have raised funding.
Company details
Schrödinger is engaged in creating computational platforms powered by physics to transform therapeutics and materials discovery. The company operates in life sciences and materials science sectors, offering solutions for drug discovery, biologics, and advanced materials design. Key areas include small molecule discovery, antibody design, and polymeric materials. Software products like Maestro, LiveDesign, and FEP are provided alongside services for collaborative research. The company also advances a proprietary pipeline of therapeutics targeting high-value, validated targets. Educational resources and certification courses are offered to support digital chemistry adoption across industries.
- Headquarters New York, United States
- Employees 891
- Founders William A Goddard
- Stage Acquired
- SectorsIndustrial Goods & ManufacturingHealthcare Technology
- Email••••••••
- Phone•••• ••••
- Website schrodinger.com
- Social LinkedIn X Instagram
- Acquired by Baron Funds (May 2020)
- Legal Name Schrodinger, Inc.
- Indian entity revenue₹138 Cr
FY 2025 · +21% YoY
- Indian entity net profit₹18.25 Cr
FY 2025 · 13% margin
- Indian entity EBITDA₹31.09 Cr
FY 2025 · 22% margin
- Total Equity Funding$162M (USD)
in 10 rounds
- Latest Funding Round$4.9M (USD), Grant
Nov 2021
- InvestorsWuXi AppTec
& 11 more
- Employee Count891
- Acquired byBaron Funds
(May 2020)
Associated legal entities of Schrödinger
Schrödinger operates through Schrodinger India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Schrodinger India Private Limited CIN U72200TG2021FTC155266 | Active | 24 Sep 2021 | Hyderabad, Telangana | ₹138 Cr | 146 | 5 | View details |
Products & Services of Schrödinger
Schrödinger offers a comprehensive portfolio of products and services, including Maestro, LiveDesign, MS Maestro, and FEP+.
Software for molecular modeling in drug discovery research.
Platform for collaborative drug design and data management.
Tool for molecular modeling in materials science applications.
Software for free energy calculations in drug design.
Funding Insights of Schrödinger
Schrödinger has successfully raised a total of $162M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $4.9 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $162M
- Total Rounds 10
- Last Round Grant — $4.9M
- First Round $1.04M
(Jan 2007)
- Investors Count 12
All 10 funding rounds of Schrödinger with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $4.9M | Grant | – | – | |
| May 2019 | $110M | Series D | – | Gates Foundation, WuXi AppTec | |
| Jun 2015 | $22M | Series C | – | – | – |
| Jan 2015 | $377,710 | Grant | – | – | |
| Dec 2012 | $20M | Angel Round | – | Bill Gates | – |
| Sep 2010 | $1.04M | Grant | – | – | |
| Apr 2010 | $10M | Series A | – | – | – |
| Mar 2009 | $300,843 | Grant | – | – | |
| Apr 2008 | $300,843 | Grant | – | – | |
| Jan 2007 | $1.04M | Grant | – | – |
12 investors in total: 11 institutional and 1 angel.
Investors in Schrödinger
Schrödinger has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include WuXi AppTec, Gates Foundation and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
Venture capital investments are directed toward multiple sectors. | 2006 | qimingvc.com | Shanghai, China | |
Corporate backed venture capital fund investing in multiple sectors | gv.com | Mountain View, United States | ||
Growth-stage companies are invested in by this venture capital fund. | pavilioncapital.com | New York, United States | ||
Long-term private equity investments in transformational opportunities are pursued. | invus.com | New York, United States | ||
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States | |
Provider of CRO and CDMO services | 2000 | wuxiapptec.com | Shanghai, China | |
Asset management services for growth equity investments through mutual funds and strategies. | baronfunds.com | |||
Offers capital markets investing through qualitative and quantitative research across asset classes. | 2005 | laurioncap.com | New York, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Schrödinger
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Schrodinger India Private Limited (Schrödinger)
Schrodinger India Private Limited is the primary company behind Schrödinger. The board of Schrodinger India Private Limited currently have 4 directors; the longest-serving is Puja Khemka, appointed in 2021. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Puja Khemka DIN 08500093 | Whole-time director | 24 Sep 2021 | 5 yrs 1 mo | Schrodinger India Private Limited |
| Kenneth Patrick Lorton DIN 09332875 | Director | 24 Sep 2021 | 5 yrs 1 mo | Schrodinger India Private Limited |
| Yvonne Kim Tran DIN 09332876 | Director | 24 Sep 2021 | 5 yrs 1 mo | Schrodinger India Private Limited |
| Ramakrishna Annabhimoju DIN 11515644 | Additional Director | 05 Feb 2026 | 9 mo | Schrodinger India Private Limited |
People of Schrödinger
199 people are tracked at Schrödinger (84 in leadership, 13 in board & advisors, 102 in team); the tracked headcount is 891.
| Name | Role | Group |
|---|---|---|
William A Goddard | Co-Founder | Leadership |
Ramy Farid | CEO & President | Leadership |
Tomoko Satoh | VP, Representative Director, Japan Operations | Leadership |
Christiane Braun | Director Marketing Europe | Leadership |
Karen Akinsanya | EVP, Chief Biomedical Scientist, Head of Discovery R&D | Leadership |
| EVP & Chief Legal Officer | Leadership | |
Michelle King | Director Of Growth, Material Science | Leadership |
Naveen Kumar Thakral | Sr. Director, Pharmaceutical Sciences | Leadership |
Adrian Komainda | Executive Director Materials Science Business EMEA | Leadership |
Helge Weissig | Senior Director, Discovery Informatics | Leadership |
Mathew D. Halls | VP, Materials Science | Leadership |
Margaret Dugan | Chief Medical Officer | Leadership |
Jacquelynne Romo | Senior Director, Sales | Leadership |
| SVP & CTO | Leadership | |
Richie Jain | SVP, Strategic Finance & Head of Corporate & Business Development | Leadership |
James Baxendale | VP Enterprise Informatics | Leadership |
Dan Cannon | Director, Head Of Biologics Modelling | Leadership |
Adam Levinson | Director, Medicinal Chemistry | Leadership |
Zachary Johnson | Senior Director Of Structural Biology | Leadership |
Saleem Abdullahi | Executive Assistant To SVP & Chief Biomedical Scientist And Svp, Science | Leadership |
179 more people are available in the full profile.
Complete people profiles for Schrödinger
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Schrödinger
Schrödinger is a publicly listed company on the NASDAQ with ticker symbol SDGR in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date06 Feb 2020
- Listed onNASDAQ: SDGR
- Listed entitySchrodinger, Inc.
- Exchange sectorTechnology services
- ISINUS80810D1037
- Share price$25.89 (-0.08% on the day) · 2026-10-13
- Market capitalisation$1.94B
- EPS (diluted, trailing year)$-0.74
- Volume (last session)1,302,178
Financials of Schrödinger
Figures of Schrodinger India Private Limited, the primary company behind Schrödinger, for FY 2025. Revenue was ₹138 Cr (+21% year on year). Net profit was ₹18.25 Cr (13% margin). EBITDA was ₹31.09 Cr (22% margin). Revenue has grown at a compounded annual rate of +78% over three years.
- ₹138 CrRevenue · FY 2025 · +21% YoY
- ₹18.25 CrNet profit · 13% margin
- ₹31.09 CrEBITDA · 22% margin
- ₹37.50 CrPaid-up capital
- 146Employees (provident fund records)
- +78%Revenue CAGR, 3 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $255.9M | -$103.3M | -$160.9M |
| 2024 | $207.5M | -$187.1M | -$203.1M |
| 2023 | $216.7M | $40.7M | -$171.9M |
| 2022 | $181.0M | -$149.2M | -$142.5M |
| 2021 | $137.9M | -$100.4M | -$108.6M |
Balance sheet, profit and loss, cash flow and ratios of Schrodinger India Private Limited are on its company page.
Detailed financial statements for Schrödinger
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Schrödinger
5 dated milestones of Schrödinger across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Schrödinger is founded.
- Funding First funding round of $1.0M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Baron Funds.
- Funding Latest funding round, Grant, of $4.9M.
Competitors of Schrödinger
Schrödinger has 3 listed competitors in our database, 3 of them funded. They include Nimbus Therapeutics, EvolutionaryScale and Evozyne.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nimbustx.com | 2009 | Cambridge, United States | $685M | 81 | Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed. | |
| evolutionaryscale.ai | 2023 | New York, United States | $142M | Provider of an AI models for protein design | ||
| evozyne.com | 2020 | Chicago, United States | $144.37M | Developer of proteins using protein engineering technology |
Detailed competitors of Schrödinger
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Schrödinger
The website of Schrödinger (schrodinger.com) receives about 197.3K visits a month.
- Monthly visits197.3K
▼ 4.5% vs previous month
Websites whose visitors overlap most with Schrödinger. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| chemcomp.com | 100% | 23.1K | #1,100,676 | View details | |
| acdlabs.com | 98% | 177.1K | #258,053 | View details | |
| eyesopen.com | 90% | 25.2K | #1,006,842 | View details | |
daylight.com | daylight.com | 82% | #1,065,024 | – | |
| hyper.com | 79% | 2.4K | #8,363,100 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Schrödinger
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Materials Equipment & Tech
3 companies that operate in the same segment as Schrödinger (Materials Equipment & Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Critical minerals are recovered from e-waste via electro-extraction technology. | 2017 | Knoxville, Tennessee, United States | USD 65.23 M | |||
Provider of AI-based solutions for materials informatics | 2013 | Redwood City, California, United States | USD 81.26 M | 53 | ||
Novi is focused on enhancing AI-driven shopping experiences. | 2019 | Larkspur, Colorado, United States | USD 51.65 M | 16 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Schrödinger
Complete news archive for Schrödinger
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Schrödinger
Schrödinger was founded in 1990 and raised its 1st funding round 17 years after it was founded.
Schrödinger is headquartered in New York, United States. It is registered at New York, New York, United States.
Ramy Farid is the CEO of Schrödinger, as recorded in our data.
Schrödinger is a funded company, having raised a total of $162M across 10 funding rounds to date. The company's 1st funding round was a Grant of $1.04M, raised on Jan 2007.
Schrödinger has 891 employees.
The primary company behind Schrödinger, Schrodinger India Private Limited, reported revenue of ₹138 Cr for FY 2025, up 21% year on year.
Schrödinger is engaged in creating computational platforms powered by physics to transform therapeutics and materials discovery. The company operates in life sciences and materials science sectors, offering solutions for drug discovery, biologics, and advanced materials design. Key areas include small molecule discovery, antibody design, and polymeric materials. Software products like Maestro, LiveDesign, and FEP are provided alongside services for collaborative research. The company also advances a proprietary pipeline of therapeutics targeting high-value, validated targets. Educational resources and certification courses are offered to support digital chemistry adoption across industries.
Schrödinger's top competitors include Nimbus Therapeutics, EvolutionaryScale and Evozyne.
Schrödinger offers Maestro, LiveDesign, MS Maestro, and FEP+.
Yes, Schrödinger is publicly traded on NASDAQ under the ticker symbol SDGR.
Schrödinger has 12 investors. Key investors include WuXi AppTec, Gates Foundation, HHS, European Union, and Qiming Venture Partners.
Schrödinger operates through Schrodinger India Private Limited.